Clinical Trial Update: A Study of MVA85A in Healthy Infants [Phase 2]

View source ↗

Summary

A Phase 2 study of the TB vaccine MVA85A in healthy infants has completed, with results posted in December 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• MVA85A (Modified Vaccinia Ankara expressing antigen 85A)

Snippet

Sponsor: Aeras | Conditions: Tuberculosis | Phase 2 | Status: COMPLETED | Results posted: 2013-12-12